Neoplasm, Residual

"Neoplasm, Residual" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Remnant of a tumor or cancer after primary, potentially curative therapy.

Descriptor ID	D018365
MeSH Number(s)	C04.697.700 C23.550.727.700
Concept/Terms	Neoplasm, Residual Neoplasm, Residual Residual Neoplasms Residual Neoplasm Minimal Residual Disease Minimal Disease, Residual Residual Minimal Disease Residual Minimal Diseases Residual Disease, Minimal Minimal Residual Diseases Residual Cancer Residual Cancer Cancer, Residual Residual Cancers Residual Tumor Residual Tumor Residual Tumors Residual Tumour Residual Tumours Tumour, Residual

Below are MeSH descriptors whose meaning is more general than "Neoplasm, Residual".

Diseases [C]
Neoplasms [C04]
Neoplastic Processes [C04.697]
Neoplasm, Residual [C04.697.700]
Pathological Conditions, Signs and Symptoms [C23]
Pathologic Processes [C23.550]
Neoplastic Processes [C23.550.727]
Neoplasm, Residual [C23.550.727.700]

Below are MeSH descriptors whose meaning is related to "Neoplasm, Residual".

Below are MeSH descriptors whose meaning is more specific than "Neoplasm, Residual".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Neoplasm, Residual" by people in this website by year, and whether "Neoplasm, Residual" was a major or minor topic of these publications.

Bar chart showing 115 publications over 29 distinct years, with a maximum of 14 publications in 2020

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	0	1	1
1997	0	2	2
1998	1	1	2
1999	1	2	3
2000	0	3	3
2001	0	4	4
2002	1	1	2
2003	0	2	2
2004	0	4	4
2005	1	2	3
2006	0	2	2
2007	0	1	1
2008	0	3	3
2009	0	2	2
2010	3	3	6
2011	0	2	2
2012	1	1	2
2013	0	5	5
2014	2	5	7
2015	1	7	8
2016	1	4	5
2017	0	5	5
2018	3	3	6
2019	2	1	3
2020	2	12	14
2021	1	6	7
2022	0	5	5
2024	1	4	5
2025	0	1	1

Below are the most recent publications written about "Neoplasm, Residual" by people in Profiles.

King AJ, Steenkamp R, Graumann O, Wah TM, Alcorn D, Nielsen TK, de Kerviler E, Zondervan PJ, Walkden M, Lagerveld B, Van Strijen M, Keeley FX, Breen DJ. Risk Factors for Residual Unablated Tumour Following CT-Guided Percutaneous Renal Cryoablation: Lessons from the EuRECA Registry. Cardiovasc Intervent Radiol. 2025 Feb; 48(2):196-204.

View in: PubMed
Saeed A, Yousuf S, Noverati N, Chen A, Saleem N, Farooq U, Muniraj T, Persaud A, Xiao Y, Kumar A, Schlachterman A, Kowalski T, Adler D, Kamal F. Cold- versus hot-snare endoscopic mucosal resection of colorectal polyps: meta-analysis of randomized controlled trials. Gastrointest Endosc. 2025 06; 101(6):1239-1243.e2.

View in: PubMed
Barata PC, Zarrabi KK, Bex A, Grivas P, Hermann K, Hofman MS, Li R, Lopez-Beltran A, Padani AR, Powles T, Taplin ME, Loriot Y. Novel Methods to Assess Tumor Burden and Minimal Residual Disease in Genitourinary Cancers. Eur Urol. 2025 Apr; 87(4):412-423.

View in: PubMed
Montagna G, Laws A, Ferrucci M, Mrdutt MM, Sun SX, Bademler S, Balbaloglu H, Balint-Lahat N, Banys-Paluchowski M, Barrio AV, Benson J, Bese N, Boughey JC, Boyle MK, Diego EJ, Eden C, Eller R, Goldschmidt M, Hlavin C, Heidinger M, Jelinska J, Karadeniz Cakmak G, Kesmodel SB, King TA, Kuerer HM, Loesch J, Milardi F, Murawa D, Moo TA, Menes TS, Passeri D, Pastoriza JM, Perhavec A, Pislar N, Polidorio N, Rami A, Ryu JM, Schulz A, Sevilimedu V, Ugurlu MU, Uras C, van Hemert A, Wong SM, Yoo TR, Zhang JQ, Karanlik H, Cabioglu N, Peeters MV, Morrow M, Weber WP. Nodal Burden and Oncologic Outcomes in Patients With Residual Isolated Tumor Cells After Neoadjuvant Chemotherapy (ypN0i+): The OPBC-05/ICARO Study. J Clin Oncol. 2025 03; 43(7):810-820.

View in: PubMed
Kataoka K, Mori K, Nakamura Y, Watanabe J, Akazawa N, Hirata K, Yokota M, Kato K, Kotaka M, Yamazaki K, Kagawa Y, Mishima S, Ando K, Miyo M, Yukami H, Laliotis G, Sharma S, Palsuledesai CC, Rabinowitz M, Jurdi A, Liu MC, Aleshin A, Kotani D, Bando H, Taniguchi H, Takemasa I, Kato T, Yoshino T, Oki E. Survival benefit of adjuvant chemotherapy based on molecular residual disease detection in resected colorectal liver metastases: subgroup analysis from CIRCULATE-Japan GALAXY. Ann Oncol. 2024 Nov; 35(11):1015-1025.

View in: PubMed
Fletcher SA, Pallauf M, Watts EK, Lombardo KA, Campbell JA, Rezaee ME, Roupr?t M, Boorjian SA, Potretzke AM, Roshandel MR, Ploussard G, Djaladat H, Ghoreifi A, Mari A, Campi R, Khene ZE, Raman JD, Kikuchi E, Rink M, Abdollah F, Boormans JL, Fujita K, D'Andrea D, Soria F, Breda A, Hoffman-Censits J, McConkey DJ, Shariat SF, Pradere B, Singla N. Oncologic Outcomes in Patients with Residual Upper Tract Urothelial Carcinoma Following Neoadjuvant Chemotherapy. Eur Urol Oncol. 2024 Oct; 7(5):1061-1068.

View in: PubMed
Zhang YH, Montagna G, Flynn J, Gillespie EF, Mamtani A, Zhang Z, Braunstein LZ, Powell SN, Morrow M, Barrio A, Khan AJ. Outcomes of Breast Cancer Patients with High Volume of Residual Disease Following Neoadjuvant Chemotherapy. Int J Radiat Oncol Biol Phys. 2023 03 01; 115(3):622-628.

View in: PubMed
Wierda WG, Brown J, Abramson JS, Awan F, Bilgrami SF, Bociek G, Brander D, Chanan-Khan AA, Coutre SE, Davis RS, Eradat H, Fletcher CD, Gaballa S, Ghobadi A, Hamid MS, Hernandez-Ilizaliturri F, Hill B, Kaesberg P, Kamdar M, Kaplan LD, Khan N, Kipps TJ, Ma S, Mato A, Mosse C, Schuster S, Siddiqi T, Stephens DM, Ujjani C, Wagner-Johnston N, Woyach JA, Ye JC, Dwyer MA, Sundar H. NCCN Guidelines? Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 3.2022. J Natl Compr Canc Netw. 2022 06; 20(6):622-634.

View in: PubMed
O'Cearbhaill RE, P?rez-Fidalgo JA, Monk BJ, Tusquets I, McCormick C, Fuentes J, Moore RG, Vulsteke C, Shahin MS, Forget F, Bradley WH, Hietanen S, O'Malley DM, D?rum A, Slomovitz BM, Baumann K, Selle F, Calvert PM, Artioli G, Levy T, Kumar A, Malinowska IA, Li Y, Gupta D, Gonz?lez-Mart?n A. Efficacy of niraparib by time of surgery and postoperative residual disease status: A post hoc analysis of patients in the PRIMA/ENGOT-OV26/GOG-3012 study. Gynecol Oncol. 2022 07; 166(1):36-43.

View in: PubMed
Arisi MF, Dotan E, Fernandez SV. Circulating Tumor DNA in Precision Oncology and Its Applications in Colorectal Cancer. Int J Mol Sci. 2022 Apr 18; 23(8).

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement